New imaging agent could spot recurrent brain metastases more accurately
Diagnosis
Ongoing
This study tests a new imaging agent called RAD101, used with a PET scan, to see if it can better detect brain metastases that have come back after treatment. About 30 adults with certain cancers (like lung, breast, or melanoma) and suspected recurrent brain tumors will receive o…
Phase: PHASE2 • Sponsor: Radiopharm Theranostics, Ltd • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC